EWG Elevate’s Colgate-Palmolive CL Stock Holding History

EWG Elevate’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-260	Closed	-$20.5K	–	186
2022 Q4	$20.5K	Buy	+260	New	+$19.5K	0.01%	283

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EWG Elevate's CL Position: Q1 2023 in Review

EWG Elevate sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 260 shares — an estimated $20.5K sold.

EWG Elevate first reported a position in CL in Q4 2022 and held it in 1 quarter. The position peaked at $20.5K in Q4 2022. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

EWG Elevate reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 260 Colgate-Palmolive shares in Q1 2023, an estimated $20.5K.
EWG Elevate first reported a position in Colgate-Palmolive in Q4 2022 and held it in 1 quarter.
EWG Elevate's Colgate-Palmolive position peaked at $20.5K in Q4 2022.
1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.